In our current study, among the lung cancer patients who underwent testing for EGFR mutations, 49.10% had mutations in the younger group, and 44.81% had mutations in the older group; the difference was not significant, which was consistent with a recent study in Chinese patients46. This evidence concerns the gene EGFR and lung cancer.